Targeting cancer stem cells by nutraceuticals for cancer therapy
Seminars in Cancer Biology, ISSN: 1044-579X, Vol: 85, Page: 234-245
2022
- 29Citations
- 55Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations29
- Citation Indexes29
- 29
- CrossRef8
- Captures55
- Readers55
- 55
- Mentions2
- News Mentions2
- News2
Most Recent News
A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy
Introduction Melanoma is a common malignant skin tumor that is highly aggressive and dangerous.1,2 In clinical practice, the traditional treatment of melanoma is limited to
Review Description
Accumulating evidence has demonstrated that cancer stem cells (CSCs) play an essential role in tumor progression and reoccurrence and drug resistance. Multiple signaling pathways have been revealed to be critically participated in CSC development and maintenance. Emerging evidence indicates that numerous chemopreventive compounds, also known as nutraceuticals, could eliminate CSCs in part via regulating several signaling pathways. Therefore, in this review, we will describe the some natural chemopreventive agents that target CSCs in a variety of human malignancies, including soy isoflavone, curcumin, resveratrol, tea polyphenols, sulforaphane, quercetin, indole-3-carbinol, 3,3′-diindolylmethane, withaferin A, apigenin, etc. Moreover, we discuss that eliminating CSCs by nutraceuticals might be a promising strategy for treating human cancer via overcoming drug resistance and reducing tumor reoccurrence.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1044579X21002029; http://dx.doi.org/10.1016/j.semcancer.2021.07.008; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85110685492&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34273521; https://linkinghub.elsevier.com/retrieve/pii/S1044579X21002029; https://dx.doi.org/10.1016/j.semcancer.2021.07.008
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know